Fasoracetam
From Wikipedia, the free encyclopedia
 |
|
|
Fasoracetam
|
|
| Systematic (IUPAC) name | |
| (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C10H16N2O2 |
| Mol. mass | 196.246 g/mol |
| SMILES | search in , |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled (US) |
| Routes | Oral |
Fasoracetam is a nootropic drug of the racetam family.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
